Related Experiment Video

Updated: May 30, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression

C Oneyama1, E Morii, D Okuzaki

  • 1Department of Oncogene Research, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan. coneyama@biken.osaka-u.ac.jp

Oncogene
|August 24, 2011
PubMed

Insights

MicroRNA-542-3p downregulation is linked to cancer progression through c-Src pathways. Restoring miR-542-3p levels inhibits tumor growth by targeting integrin-linked kinase (ILK).

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • The tyrosine kinase c-Src is frequently upregulated in human cancers, but its precise role in tumor progression is not fully understood.
  • Understanding the molecular mechanisms driving c-Src-mediated oncogenesis is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the relationship between microRNA-542-3p (miR-542-3p) and c-Src in human cancer progression.
  • To identify the molecular targets of miR-542-3p and elucidate its role in c-Src-driven oncogenic pathways.

Main Methods:

  • Analysis of miR-542-3p expression in c-Src-overexpressing cancer cells and human colon cancer tissues.
  • Functional studies involving ectopic expression of miR-542-3p to assess its impact on tumor growth.
  • Identification and validation of integrin-linked kinase (ILK) as a direct target of miR-542-3p.
  • Investigation of signaling pathways regulated by ILK, including FAK/c-Src and AKT pathways.

Main Results:

  • miR-542-3p was significantly downregulated in c-Src-overexpressing cancer cells and correlated with tumor progression in colon cancer.
  • Ectopic expression of miR-542-3p suppressed tumor growth and invasion.
  • ILK was identified as a direct target of miR-542-3p; ILK upregulation promoted cell adhesion and invasion via the FAK/c-Src pathway.
  • miR-542-3p expression was inversely regulated by activated c-Src signaling components like EGFR, K-Ras, and MAPK/ERK pathway.

Conclusions:

  • A novel regulatory circuit involving c-Src, miR-542-3p, and ILK (c-Src-miR-542-3p-ILK-FAK) is identified as a key driver of tumor progression.
  • This circuit represents a potential therapeutic target for cancers characterized by c-Src upregulation.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.